Consumer Healthcare Products New Zealand (CHPNZ), the peak industry body for over-the counter medicines, has welcomed the passing into law of the Medicines Amendment Bill meaning quicker access for kiwis to innovative and safe prescription medicines.
Acting PM and Associate Minister of Health Hon David Seymour, and Scott Milne (CHPNZ CE) take to Mission Bay for the shortest day of the year to highlight how over-the-counter medicines (OTC) can be a safe and effective solution to coughs and colds.
The pharmaceutical industry and a medicines reclassification expert have welcomed the Government’s proposal to update Medsafe’s approvals process, but some details still need to be ironed out.
Over-the-counter medicines peak body Consumer Health Products New Zealand (CHPNZ) recently welcomed the Associate Minister of Health (Pharmac and Medsafe) to its 2024 Annual General Meeting in Auckland.
The CHPNZ AGM will be in person only at 9:30am on Friday, August 16 2024
Returned to many pharmacies in time for winter are products containing pseudoephedrine – a highly effective treatment for cough and cold symptoms, including nasal congestion.
CHPNZ CE Scott Milne has met with the Associate Minister of Health, Hon Casey Costello MP, at her Parliamentary offices.
It has been a busy few months since our last update.
The Pseudoephedrine Bill (PSE) has moved at breakneck speed and Executive Director Scott Milne did an excellent job on behalf of the membership for both written and oral submissions to Parliament’s Health Select Committee.
With the industry still awaiting more information on the repeal to the Therapeutic Products Act 2023 and the content of its likely replacement, CHPNZ has reached out to the Associate Health Minister in charge of the new legislation, Hon Casey Costello, looking forward to meeting with her in the coming month. As part of the coalition government’s 100-day plan, work on the appeal of the Act has begun.
The Consumer Healthcare Products Association of New Zealand (CHPNZ) has welcomed the release today of the pathway to bring the supply of the cold and flu medication pseudoephedrine back to pharmacies.